U.S. Markets closed

Company News For Mar 19, 2019

Zacks Equity Research
Radius Health's (RDUS) lead drug, Tymlos, gains traction in 2018. Let us see how the drug will fare in 2019 amid increasing competition.
  • Overstock.com, Inc.’s OSTK shares dipped 5.3% after the company reported fourth quarter 2018 loss per share of $1.15, wider than the Zacks Consensus Estimate of a loss of $0.67 a share
  • Fidelity National Information Services, Inc.’s FIS shares declined 0.7% after the company announced that it was buying Worldpay, Inc. WP in a cash-and-stock deal worth $43 billion
  • Shares of Edwards Lifesciences Corporation EW surged 6.2% after the company reported positive results from studies related to its non-invasive heart valve replacement systems
  • Shares of Dermira, Inc. DERM rallied 82.2% after the company announced positive results from the mid-stage trial of its treatment for moderate-to-severe atopic dermatitis

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Overstock.com, Inc. (OSTK) : Free Stock Analysis Report
Edwards Lifesciences Corporation (EW) : Free Stock Analysis Report
Dermira, Inc. (DERM) : Free Stock Analysis Report
Fidelity National Information Services, Inc. (FIS) : Free Stock Analysis Report
Vantiv, Inc. (WP) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research